Cargando…
Ponatinib modulates the metabolic profile of obese mice by inhibiting adipose tissue macrophage inflammation
Obesity-induced metabolic syndrome is a rapidly growing conundrum, reaching epidemic proportions globally. Chronic inflammation in obese adipose tissue plays a key role in metabolic syndrome with a series of local and systemic effects such as inflammatory cell infiltration and inflammatory cytokine...
Autores principales: | Lin, Zhuomiao, Lin, Xiaochun, Lai, Ying, Han, Congcong, Fan, Xinran, Tang, Jie, Mo, Shiqi, Su, Jiahui, Liang, Sijia, Shang, Jinyan, Lv, Xiaofei, Guo, Siwan, Pang, Ruiping, Zhou, Jiaguo, Zhang, Tingting, Zhang, Feiran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705588/ https://www.ncbi.nlm.nih.gov/pubmed/36457708 http://dx.doi.org/10.3389/fphar.2022.1040999 |
Ejemplares similares
-
MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis
por: Su, Yingxue, et al.
Publicado: (2019) -
Ponatinib-Induced Cerebrovascular Accident (CVA)
por: Azad, Farhan, et al.
Publicado: (2022) -
Ponatinib‐induced ichthyosiform eruption
por: Kluger, Nicolas, et al.
Publicado: (2021) -
Eruptive melanocytic nevi associated with ponatinib
por: Devred, Inès, et al.
Publicado: (2018) -
Reengineering Ponatinib to Minimize Cardiovascular Toxicity
por: Hnatiuk, Anna P., et al.
Publicado: (2022)